about
Genmab is a Copenhagen-based biotechnology company specializing in antibody therapeutics for the treatment of cancer. Genmab's proprietary antibody technologies are DuoBody, HexaBody, DuoHexaBody, and HexElect. Johnson & Johnson partnered with Genmab...
Read More
31.25
1.42
(4.76%)
3.5M
XNAS Volume
XNAS 07 Aug, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Genmab (ADR) Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..